Recipharm has entered into an agreement to acquire Italian contract development and manufacturing organization (CDMO) Mitim for €68 million, adding scale and capabilities to the group. Mitim is currently owned by a private Italian family and is specialized in the filling of injectable beta lactam products. It is located in Brescia close to Recipharm’s existing operations in Northern Italy. “This acquisition is very exciting for Recipharm and represents an important step in our consolidation o...